Thus, Gα11 ablation caused systemic inflammation and excess serum FGF23 in mice, suggesting that patients with FHH — at least those with GNA11 mutations — may be at risk for these complications. This evidence concerns the gene GNA11 and familial hypocalciuric hypercalcemia.